Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. We are:
• The world’s largest biotech company with truly differentiated medicines;
• The world leader in in vitro diagnostics and tissue-based cancer diagnostics;
• A frontrunner in diabetes management.
The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2017 employed about 94,000 people worldwide. In 2017, Roche invested CHF 10.4 billion in R&D and posted sales of CHF 53.3 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is also the majority shareholder in Chugai Pharmaceutical, Japan.